DERM

Journey Medical Corporation

3.87 USD
-0.26 (-6.30%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Journey Medical Corporation stock is down -15.32% since 30 days ago. The next earnings date is Mar 27, 2024. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 33.33% of the previous 2 March’s closed higher than February. 100% of analysts rate it a buy.

About Journey Medical Corporation

Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the. treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat severe recalcitrant acne; Targadox, an. oral doxycycline drug for. adjunctive therapy for severe acne, Ximino, and Exelderm cream for topical use.

  • Alliance Global Partners
    Fri Feb 16, 07:58
    buy
    initial